Cargando…

Antioxidant effects of Camellia sinensis L. extract in patients with type 2 diabetes

The prevalence of diabetes mellitus (DM) has dramatically increased in the past decade. Furthermore, increasing evidence from research shows that oxidative stress (OS) plays a crucial role in the pathogenesis of diabetes and in its complications. A search for ways to reduce oxidative damage has beco...

Descripción completa

Detalles Bibliográficos
Autores principales: Spadiene, Asta, Savickiene, Nijole, Ivanauskas, Liudas, Jakstas, Valdas, Skesters, Andrejs, Silova, Alise, Rodovicius, Hiliaras
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taiwan Food and Drug Administration 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355006/
https://www.ncbi.nlm.nih.gov/pubmed/28911467
http://dx.doi.org/10.1016/j.jfda.2014.04.001
_version_ 1784763197160423424
author Spadiene, Asta
Savickiene, Nijole
Ivanauskas, Liudas
Jakstas, Valdas
Skesters, Andrejs
Silova, Alise
Rodovicius, Hiliaras
author_facet Spadiene, Asta
Savickiene, Nijole
Ivanauskas, Liudas
Jakstas, Valdas
Skesters, Andrejs
Silova, Alise
Rodovicius, Hiliaras
author_sort Spadiene, Asta
collection PubMed
description The prevalence of diabetes mellitus (DM) has dramatically increased in the past decade. Furthermore, increasing evidence from research shows that oxidative stress (OS) plays a crucial role in the pathogenesis of diabetes and in its complications. A search for ways to reduce oxidative damage has become the focus of interest for the majority of scientists. In this study, we determined the radical scavenging activity of single green tea constituents by using an on-line high performance liquid chromatography (HPLC)–2,2-diphenyl-1-picrylhydrazyl (DPPH) method and evaluated the antioxidant effects on type 2 diabetic patients by performing a double-blind, placebo-controlled study. Epigallocatechin gallate was identified as the most potent antioxidant, contributing approximately 50% of the total antioxidant capacity of green tea extract. We also found a statistically significant decrement of lipid peroxidation markers in patients treated with green tea extract after 9 months or after 18 months of follow-up. Overall, these findings are attractive for diabetic patients, helping them to keep a high level of performance and well-being, which ultimately may delay the time of disability and reduce mortality.
format Online
Article
Text
id pubmed-9355006
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Taiwan Food and Drug Administration
record_format MEDLINE/PubMed
spelling pubmed-93550062022-08-09 Antioxidant effects of Camellia sinensis L. extract in patients with type 2 diabetes Spadiene, Asta Savickiene, Nijole Ivanauskas, Liudas Jakstas, Valdas Skesters, Andrejs Silova, Alise Rodovicius, Hiliaras J Food Drug Anal Original Article The prevalence of diabetes mellitus (DM) has dramatically increased in the past decade. Furthermore, increasing evidence from research shows that oxidative stress (OS) plays a crucial role in the pathogenesis of diabetes and in its complications. A search for ways to reduce oxidative damage has become the focus of interest for the majority of scientists. In this study, we determined the radical scavenging activity of single green tea constituents by using an on-line high performance liquid chromatography (HPLC)–2,2-diphenyl-1-picrylhydrazyl (DPPH) method and evaluated the antioxidant effects on type 2 diabetic patients by performing a double-blind, placebo-controlled study. Epigallocatechin gallate was identified as the most potent antioxidant, contributing approximately 50% of the total antioxidant capacity of green tea extract. We also found a statistically significant decrement of lipid peroxidation markers in patients treated with green tea extract after 9 months or after 18 months of follow-up. Overall, these findings are attractive for diabetic patients, helping them to keep a high level of performance and well-being, which ultimately may delay the time of disability and reduce mortality. Taiwan Food and Drug Administration 2014-05-20 /pmc/articles/PMC9355006/ /pubmed/28911467 http://dx.doi.org/10.1016/j.jfda.2014.04.001 Text en © 2014 Taiwan Food and Drug Administration https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC-BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ).
spellingShingle Original Article
Spadiene, Asta
Savickiene, Nijole
Ivanauskas, Liudas
Jakstas, Valdas
Skesters, Andrejs
Silova, Alise
Rodovicius, Hiliaras
Antioxidant effects of Camellia sinensis L. extract in patients with type 2 diabetes
title Antioxidant effects of Camellia sinensis L. extract in patients with type 2 diabetes
title_full Antioxidant effects of Camellia sinensis L. extract in patients with type 2 diabetes
title_fullStr Antioxidant effects of Camellia sinensis L. extract in patients with type 2 diabetes
title_full_unstemmed Antioxidant effects of Camellia sinensis L. extract in patients with type 2 diabetes
title_short Antioxidant effects of Camellia sinensis L. extract in patients with type 2 diabetes
title_sort antioxidant effects of camellia sinensis l. extract in patients with type 2 diabetes
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355006/
https://www.ncbi.nlm.nih.gov/pubmed/28911467
http://dx.doi.org/10.1016/j.jfda.2014.04.001
work_keys_str_mv AT spadieneasta antioxidanteffectsofcamelliasinensislextractinpatientswithtype2diabetes
AT savickienenijole antioxidanteffectsofcamelliasinensislextractinpatientswithtype2diabetes
AT ivanauskasliudas antioxidanteffectsofcamelliasinensislextractinpatientswithtype2diabetes
AT jakstasvaldas antioxidanteffectsofcamelliasinensislextractinpatientswithtype2diabetes
AT skestersandrejs antioxidanteffectsofcamelliasinensislextractinpatientswithtype2diabetes
AT silovaalise antioxidanteffectsofcamelliasinensislextractinpatientswithtype2diabetes
AT rodoviciushiliaras antioxidanteffectsofcamelliasinensislextractinpatientswithtype2diabetes